VASCULAR ACCESS SITE RUPTURE

This adverse event was reported 19 times

VASCULAR ACCESS SITE RUPTURE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ORITAVANCIN 2 0.0022
1 HYALURONIC ACID 1 0.0009
2 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 3 0.0004
3 ETELCALCETIDE 1 0.0003
4 INFLIXIMAB-DYYB 1 0.0003
5 OLOPATADINE HYDROCHLORIDE OPHTHALMIC 1 0.0002
6 IMMUNE GLOBULIN INFUSION (HUMAN) 2 0.0002
7 OLOPATADINE HYDROCHLORIDE 1 0.0002
8 AGALSIDASE BETA 1 0.0001
9 TIOTROPIUM BROMIDE INHALATION SPRAY 1 0.0001
See all drugs enriched for association with VASCULAR ACCESS SITE RUPTURE